SHH and medulloblastoma: For instance, mutations in PTCH1, SMO or SUFU and somatic amplification of GLI2 and MYCN, all deregulating Sonic hedgehog (SHH) signalling, define subgroup 2 medulloblastoma (or ‘SHH' subgroup).